Valiant Laboratories IPO
Valiant Laboratories IPO Details
-
खुलने की तिथि
27 सितंबर 2023
-
समाप्ति तिथि
03 अक्टूबर 2023
- IPO प्राइस रेंज
₹133 से ₹140
- IPO साइज़
₹ 152.46 करोड़
Valiant Laboratories IPO Timeline
Valiant Laboratories IPO Subscription Status
| तिथि | क़िब | एनआईआई | खुदरा | कुल |
|---|---|---|---|---|
| 27-Sep-23 | 0.00 | 0.10 | 0.62 | 0.33 |
| 28-Sep-23 | 0.05 | 0.29 | 1.29 | 0.72 |
| 29-Sep-23 | 1.04 | 1.52 | 3.14 | 2.19 |
| 03-Oct-23 | 20.83 | 73.63 | 16.05 | 29.75 |
अंतिम अपडेट: 03 अक्टूबर 2023 6:13 PM तक 5paisa
Established in 1980, Valiant Laboratories Limited is involved in the business of pharmaceutical ingredient manufacturing with a focus on manufacturing Paracetamol.
The company has its manufacturing facility in Palghar, Maharashtra, spanning over 2,000 square meters of land. This facility has an annual production capacity of 9,000 metric tons. Additionally, the company houses an R&D center featuring an analytical laboratory and resources dedicated to product development.
As of April 30, 2023, Valiant Laboratories employs a workforce of 86 individuals. The company also possesses Good Manufacturing Practices (GMP) for the production and distribution of bulk drugs/API, along with ISO 9001:2015 certification.
पीयर की तुलना
● Granules India Ltd
● Jagsonpal Pharmaceuticals Ltd
● Alkyl Amines Chemicals Ltd
● Laxmi Organic Industries Ltd
अधिक जानकारी के लिए:
Webstory on Valiant Laboratories IPO
| विवरण (रु. करोड़ में) | FY23 | FY22 | FY21 |
|---|---|---|---|
| राजस्व | 333.91 | 291.52 | 182.36 |
| EBITDA | 35.09 | 42.32 | 50.00 |
| पैट | 28.99 | 27.49 | 30.59 |
| विवरण (रु. करोड़ में) | FY23 | FY22 | FY21 |
|---|---|---|---|
| कुल एसेट | 212.76 | 181.81 | 106.31 |
| शेयर कैपिटल | 32.56 | 16.28 | 10.50 |
| कुल उधार | 112.26 | 110.35 | 17.73 |
| विवरण (रु. करोड़ में) | FY23 | FY22 | FY21 |
|---|---|---|---|
| ऑपरेटिंग गतिविधियों से/(इस्तेमाल की गई) नेट कैश जनरेट किया गया है | 22.96 | 2.25 | 9.10 |
| निवेश गतिविधियों से/(उपयोग में) नेट कैश | -21.18 | -12.24 | -16.67 |
| फाइनेंसिंग गतिविधियों से/(उपयोग में) नेट कैश फ्लो | -1.53 | 6.18 | 11.43 |
| कैश और कैश के बराबर में शुद्ध वृद्धि (कम) | 0.24 | -3.80 | 3.87 |
शक्तियां
1. The company has reported strong financial performance.
2. The company is working on reducing dependence on the import of raw materials.
3. The company’s Manufacturing Facility is strategically located near JNPT (Nhava Sheva) Port, Maharashtra and its registered office at Mulund West, Mumbai, Maharashtra, which ensures that it has ready access to port facilities and is able to expediently import raw materials and export products in a cost-efficient manner.
4. Highly experienced Management team.
जोखिम
1. The company solely focuses on manufacturing the paracetamol. Thus, any changes in its demand can adversely affect the business.
2. The majority of the operative income is derived from the domestic market.
3. Subject to government regulations.
4. Operates in an intensely competitive industry.
5. Pricing pressure from customers may affect the business.
6. Reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing and reimbursement could adversely affect the pricing and demand for the company’s products.
7. Restrictions on the import of raw materials may impact the business and results of operations.
8. अधिक कार्यशील पूंजी की आवश्यकताएं.
FAQ
The minimum lot size of Valiant Laboratories IPO is 105 shares and the investment required is ₹13,965.
The price band of Valiant Laboratories IPO is ₹133 to ₹140.
Valiant Laboratories IPO is open from 27th September to 3rd October 2023.
The size of Valiant Laboratories IPO is ₹152.46 cr, which includes a fresh issue of 10,890,000 equity shares.
The share allotment date of Valiant Laboratories IPO is 5th of October 2023.
The Valiant Laboratories IPO will be listed on 9th of October 2023.
Unistone Capital Pvt Ltd is the book-running lead manager for Valiant Laboratories IPO.
Valiant Laboratories plans to utilize the raised capital from IPO to:
1. To invest in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
2. To invest in VASPL to fund its working capital requirements.
3. फंड जनरल कॉर्पोरेट उद्देश्य.
To apply for Valiant Laboratories IPO, follow the steps given below:
● अपने 5paisa अकाउंट में लॉग-इन करें और मौजूदा IPO सेक्शन में समस्या चुनें
● Enter the number of lots and the price at which you wish to apply for the Valiant Laboratories IPO.
● अपनी UPI ID दर्ज करें और सबमिट पर क्लिक करें. इसके साथ, आपकी बिड एक्सचेंज के साथ दी जाएगी.
● आपको अपनी UPI ऐप में फंड ब्लॉक करने के लिए मैंडेट नोटिफिकेशन प्राप्त होगा.
Valiant Laboratories Contact Details
Valiant Laboratories Limited
104,Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West, Mumbai -400080
फोन: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: https://valiantlabs.in/
Valiant Laboratories IPO Register
लिंक इंटाइम इंडिया प्राइवेट लिमिटेड
फोन: +91-22-4918 6270
Email: valiantlaboratories.ipo@linkintime.co.in
वेबसाइट: https://linkintime.co.in/mipo/ipoallotment.html
Valiant Laboratories IPO Lead Manager
यूनिस्टोन कैपिटल प्राइवेट लिमिटेड
